Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

0.43USD
8:59pm GMT
Change (% chg)

$0.01 (+2.86%)
Prev Close
$0.42
Open
$0.42
Day's High
$0.48
Day's Low
$0.40
Volume
66,541
Avg. Vol
83,553
52-wk High
$3.30
52-wk Low
$0.27

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 37.16 -0.891
Jun '18 21.09 -1.134
Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.12 34.38
P/E High - Last 5 Yrs. -- 40.55 46.19
P/E Low - Last 5 Yrs. -- 23.99 24.58
Beta 1.69 0.91 0.91
Price to Sales (TTM) 0.26 4.00 6.26
Price to Book (MRQ) -- 5.02 5.20
Price to Tangible Book (MRQ) -- 5.76 6.73
Price to Cash Flow (TTM) -- 23.21 24.17
% Owned Institutions 21.30 0.94 1.75

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.22 4.93
Payout Ratio(TTM) -- 45.69 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 2.31 8.17
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.77 6.48
Sales - 5 Yr. Growth Rate 18.37 10.00 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 17.44 23.23
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.50
Capital Spending - 5 Yr. Growth Rate 41.15 15.23 14.62

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.20 2.30
Current Ratio (MRQ) 0.75 3.02 3.12
LT Debt to Equity (MRQ) -- 8.85 11.47
Total Debt to Equity (MRQ) -- 12.66 16.03
Interest Coverage (TTM) -9.29 35.18 30.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 54.40 54.45
Gross Margin - 5 Yr. Avg. 64.57 51.85 52.36
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.40 13.10
Operating Margin (TTM) -93.55 14.43 6.05
Operating Margin - 5 Yr. Avg. -56.18 14.54 8.39
Pre-Tax Margin (TTM) -120.18 14.96 7.01
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.97 8.67
Net Profit Margin (TTM) -120.56 11.16 3.11
Net Profit Margin - 5 Yr. Avg. -65.04 11.22 4.86
Effective Tax Rate (TTM) -- 23.47 23.27
Effective Tax Rate - 5 Yr. Avg. -- 23.66 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 997,645,050 873,304,610
Net Income/Employee (TTM) -884,286 118,307,527 103,509,255
Receivable Turnover (TTM) 2.90 5.82 5.80
Inventory Turnover (TTM) 4.45 2.68 3.57
Asset Turnover (TTM) 0.42 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.99 11.45
Return on Assets - 5 Yr. Avg. -23.23 13.28 12.50
Return on Investment (TTM) -74.47 15.55 14.96
Return on Investment - 5 Yr. Avg. -31.36 17.29 16.23
Return on Equity (TTM) -- 16.93 16.53
Return on Equity - 5 Yr. Avg. -138.91 18.21 17.36
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.68 -1.82 49 20
13 Week -21.56 -25.38 13 34
26 Week -19.03 -25.19 24 28
52 Week -49.29 -57.02 9 12
YTD 55.67 36.71 86 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.08%
# of Holders: 40
Total Shares Held: 2,332,870
3 Mo. Net Change: -658,826
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.